80 PHP String Functions (& Examples of Each)
Learn how to use PHP string functions with this comprehensive list of functions and examples of each.
Source: hubspot.com
First Occurrence News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from First Occurrence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In First Occurrence Today - Breaking & Trending Today
![How to Use Python Index [+Examples] - Vimarsana News](https://blog.hubspot.com/hubfs/Google%20Drive%20Integration/python%20index_42023.png#keepProtocol)
How to Use Python Index [+Examples]
Learn how to employ a Python index in your code, an essential skill for any beginner Python programmer.
Source: hubspot.com
Amarin Corporation plc: Amarin Announces New REDUCE-IT® Data at ACC.23/WCC Showing Benefit of VASCEPA®/VAZKEPA® (Icosapent Ethyl) in High-Risk Patients with a Recent Acute Coronary Syndrome Event
--Post-Hoc Analysis Shows IPE Significantly Reduced Risk of First, Total Ischemic Events by 37% and 36% Respectively in Patients with Recent ACS Without Increased Bleeding-- --Analysis Builds on Consistently
Source: finanznachrichten.de
Early onset of immune-mediated diseases in minority ethnic groups in the UK | BMC Medicine
The prevalence of some immune-mediated diseases (IMDs) shows distinct differences between populations of different ethnicities. The aim of this study was to determine if the age at diagnosis of common IMDs also differed between different ethnic groups in the UK, suggestive of distinct influences of ethnicity on disease pathogenesis. This was a population-based retrospective primary care study. Linear regression provided unadjusted and adjusted estimates of age at diagnosis for common IMDs within the following ethnic groups: White, South Asian, African-Caribbean and Mixed-race/Other. Potential ...
Source: biomedcentral.com
Latest analysis shows VASCEPA® (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention
A new post hoc sub-analysis of the landmark REDUCE-IT Study, published in the Journal of the American Heart Association , found VASCEPA® significantly reduced the risk of cardiovascular death,... | March 10, 2022
Source: marketscreener.com